Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!

Google+ 

Subscribe to our channel on YouTube!  YouTube  


 

 

Print  

CF Foundation Commits $13 Million More to Vertex

A first-of-its-kind drug that could change the course of cystic fibrosis now will advance on an accelerated path to clinical development. The compound called VX-770 targets CF at the molecular level.

Thanks to a new $13.3 million award from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT) to Vertex Pharmaceuticals Incorporated, researchers may be able to evaluate the drug in clinical trials later this year. VX-770 appears to restore the function of the protein that causes CF cells to be defective.

Vertex began its CF research program in May 2000 with CF Foundation support. Since then, Vertex and CFFT, the Foundation’s drug development subsidiary, have collaborated to discover and develop compounds for CF.

Posted 03/23/06

GFC Holiday Promo

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.